INC Research Holdings Inc (INCR)
$0.92
$0.04
(4.78%)
As on 26-May-2026 11:50EDT
Market cap
$48 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
0.4
Div. Yield
0 %
Quality Score
/10
Growth Score
/10
Valuation Score
/10
Momentum Score
/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-- Mln
-
ROE
-0.1 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
5.3
-
Debt to Equity
0.5
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
54,681,335
10 Years Aggregate
CFO
₪19.28 Mln
EBITDA
₪115.08 Mln
Net Profit
₪-72.34 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
INC Research Holdings Inc (INCR)
| 1.1 | 1.3 | 10.8 | -40.6 | -23.4 | -33.7 | -- |
|
BSE Sensex
| -10.2 | -0.9 | -7.6 | -7.0 | 7.1 | 8.5 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|---|
|
INC Research Holdings Inc (INCR)
| -42.8 | -60.9 | -49.1 | 398.5 | 4.8 |
|
S&P Small-Cap 600
| 4.0 | 13.9 | -17.4 | 25.3 | 9.6 |
|
BSE Sensex
| 9.1 | 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout INC Research Holdings Inc (INCR)
InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company... offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company has a strategic alliance with Cannasoul R&D Ltd. for the research, development, and commercialization of evidence-based cannabis therapeutics. The company was incorporated in 1994 and is headquartered in Herzliya, Israel. Address: 85 Medinat ha-Yehudim Street, Herzliya, Israel, 4676670 Read more
-
CEO & Director
Mr. Alexander Rabinovich
-
CEO & Director
Mr. Alexander Rabinovich
-
Headquarters
Herzliya
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for INC Research Holdings Inc (INCR)
What is the current share price of INC Research Holdings Inc (INCR) Today?
The share price of INC Research Holdings Inc (INCR) is $0.92 (NASDAQ) as of 26-May-2026 11:50 EDT. INC Research Holdings Inc (INCR) has given a return of -23.44% in the last 3 years.
What is the current PB & PE ratio of INC Research Holdings Inc (INCR)?
Since, TTM earnings of INC Research Holdings Inc (INCR) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
--
|
--
|
|
2024
|
--
|
--
|
|
2023
|
--
|
--
|
|
2022
|
3.31
|
0.30
|
|
2021
|
--
|
--
|
What is the 52 Week High and Low of INC Research Holdings Inc (INCR)?
The 52-week high and low of INC Research Holdings Inc (INCR) are Rs 1.77 and Rs 0.68 as of 26-May-2026.
What is the market cap of INC Research Holdings Inc (INCR)?
INC Research Holdings Inc (INCR) has a market capitalisation of $ 48 Mln as on 22-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in INC Research Holdings Inc (INCR)?
Before investing in INC Research Holdings Inc (INCR), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.